Hutchin Hill Capital’s Orthofix Medical OFIX Stock Holding History

Hutchin Hill Capital’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-26,700	Closed	-$966K	–	994
2016 Q4	$966K	Buy	26,700 +9,300	+53%	+$353K	0.03%	467
2016 Q3	$744K	Buy	+17,400	New	+$777K	0.02%	423
2016 Q2	–	Sell	-20,300	Closed	-$843K	–	670
2016 Q1	$843K	Buy	+20,300	New	+$796K	0.02%	458

Other funds holding OFIX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OCM

Oakview Capital Management Dallas, Texas $21.6M AUM 20.25% 1-Year Est. Return

Hutchin Hill Capital's OFIX Position: Q1 2017 in Review

Hutchin Hill Capital sold out of Orthofix Medical (OFIX) in Q1 2017, closing a stake of 26,700 shares — an estimated $966K sold.

Hutchin Hill Capital first reported a position in OFIX in Q1 2016 and held it in 3 quarters. The position peaked at $966K in Q4 2016. 137 funds tracked by Wall St. Rank hold OFIX as of Q1 2017.

Hutchin Hill Capital reported no remaining Orthofix Medical position as of Q1 2017 after selling out during the quarter.
Hutchin Hill Capital sold 26,700 Orthofix Medical shares in Q1 2017, an estimated $966K.
Hutchin Hill Capital first reported a position in Orthofix Medical in Q1 2016 and held it in 3 quarters.
Hutchin Hill Capital's Orthofix Medical position peaked at $966K in Q4 2016.
137 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2017.

Based on Hutchin Hill Capital's 13F filing for Q1 2017, filed 15 May 2017.